The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry
Launched by NOVA SCOTIA HEALTH AUTHORITY · May 11, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Canadian Depression Research and Intervention Network (CDRIN) Maritimes Registry is a study aimed at improving care and treatment for people dealing with depression, post-traumatic stress disorder, bipolar disorder, and other mood disorders. This project will create a system that combines assessment, treatment, research, and education, focusing on the needs of individuals with these conditions, including input from those who have lived through them. By establishing a patient registry, the researchers hope to gather valuable information that can help evaluate and improve current services, ensure treatment options are tailored to patients’ needs, and develop more effective treatments through research.
Anyone seeking help for mental health issues in the maritime provinces of Canada could be eligible to participate, regardless of their specific diagnosis. Participants should be able to provide consent or have someone who can consent on their behalf, and they need to speak either English or French. By joining the registry, participants can expect to contribute to important research that aims to enhance the quality of care for everyone affected by mental health challenges. This study will also train future researchers and healthcare providers, ensuring that the focus remains on improving the experience of patients and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • male or female
- • seeking or receiving help for mental health related problems in the maritime provinces of Canada
- • able to provide informed consent or have an appropriate substitute decision maker that can provide consent on their behalf.
- • English or French speaking
- Exclusion Criteria:
- • There are no exclusion criteria related to age, sex, or ethnicity.
- • Whilst the recruitment will be targeted to include individuals suffering with depression and other types of mental illness, no specific diagnosis is required for participation in the registry.
- • unable to provide informed consent or does not have an appropriate substitute decision maker that can provide consent on their behalf
- • does not speak English or French
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Rudolf Uher, MD, PhD
Principal Investigator
Nova Scotia Health Authority
David J Pilon, PhD
Study Director
Nova Scotia Health Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials